Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options
- 15 March 2011
- journal article
- review article
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 24 (2) , 207-218
Abstract
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous reactions that are medication-induced in most instances. While the clinical manifestations of SJS and TEN are well-defined, the optimal treatment for these disorders is not. Case reports have shown benefit with the use of a variety of agents including tumor necrosis factor-alpha inhibitors and cyclophosphamide, whereas thalidomide was associated with an increased mortality. Plasmapheresis and cyclosporine have also demonstrated efficacy anecdotally, albeit with an even smaller number of cases in the literature. Most of the reporting has focused on the use of systemic corticosteroids and intravenous immunoglobulin (IVIG) for these severe reactions. The majority of studies analyzing the use of IVIG in the treatment of SJS/TEN show a benefit, though more recent series cast doubt upon this conclusion. The results of these studies are summarized in this present review study.Keywords
This publication has 66 references indexed in Scilit:
- Toxic epidermal necrolysisJournal of the American Academy of Dermatology, 2007
- Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysisAnnals of Allergy, Asthma & Immunology, 2006
- Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cellsJournal of Allergy and Clinical Immunology, 2004
- A Multicenter Review of Toxic Epidermal Necrolysis Treated in U.S. Burn Centers at the End of the Twentieth CenturyJournal of Burn Care & Rehabilitation, 2002
- Immunoregulatory Effector Cells in Drug-Induced Toxic Epidermal NecrolysisThe American Journal of Dermatopathology, 2000
- SCORTEN: A Severity-of-Illness Score for Toxic Epidermal NecrolysisJournal of Investigative Dermatology, 2000
- Death Receptors in Cutaneous Biology and DiseaseJournal of Investigative Dermatology, 2000
- TOXIC EPIDERMAL NECROLYSISDermatologic Clinics, 2000
- Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysisThe Lancet, 1998
- Plasmapheresis in severe drug-induced toxic epidermal necrolysisArchives of Dermatology, 1985